UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000038202
Receipt number R000043534
Scientific Title Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)
Date of disclosure of the study information 2019/10/07
Last modified on 2023/08/30 12:11:47

No. Disposal Last modified on Item of update
1 Insert 2019/10/04 09:56:35
2 Update 2020/04/10 10:20:46 TEL
TEL
Institutions
3 Update 2020/04/10 12:14:51 Classification by specialty
Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
4 Update 2020/04/10 14:21:52 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
5 Update 2020/04/10 14:25:57 Recruitment status
Date of IRB
6 Update 2020/04/10 15:22:59 TEL
7 Update 2020/10/05 09:53:07 Anticipated trial start date
8 Update 2021/08/16 10:45:17 Condition
Condition
Narrative objectives1
Narrative objectives1
Trial characteristics_1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
9 Update 2021/08/16 12:10:46 Basic design
Randomization
Randomization unit
Control
Blocking
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
10 Update 2021/08/16 12:19:00 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
TEL
Email

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
TEL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
TEL
Email
Organization1
Address1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
11 Update 2022/03/03 16:13:47 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
12 Update 2022/03/03 16:20:00 Institutions
13 Update 2022/03/03 16:24:25 Recruitment status
Anticipated trial start date
Last follow-up date
14 Update 2023/08/29 14:59:42 Key secondary outcomes
15 Update 2023/08/29 15:01:40 Key exclusion criteria
16 Update 2023/08/29 15:45:36 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
TEL
Email

Last name of contact person

Last name of contact person
TEL
Email
Name of person sending information
Name of person sending information
TEL
Email
17 Update 2023/08/29 15:49:50 Last follow-up date
18 Update 2023/08/30 12:11:47 Organization
Organization
Organization